Life Sciences Archivi - Pagina 5 di 7

17 luglio 2023

Extracorporeal Membrane Oxygenation Machine Industry Growth and Future Scope

Extracorporeal membrane oxygenation (ECMO) includes pumping blood outside the body to a lung-heart machine, eliminating carbon dioxide and returning oxygen-rich blood to the body’s tissues. The heart-lung machine’s membrane oxygenator receives blood from the right portion of the heart, rewarms it, and then returns it to the body.

With the help of this technique, the lungs and heart can rest and recover since the blood may “bypass” them. When the lungs and heart require assistance so that you can recuperate, ECMO is utilized in critical care conditions. It can treat infections including ARDS, COVID-19, and others. The global extracorporeal membrane oxygenation machine market is on track to hitting $834.5 million value by 2030.

Who Is Eligible for ECMO Therapy?

For patients suffering from severe injury or infection, lung failure, cardiac arrest, or heart failure, doctors may advise ECMO. To keep a seriously sick patient stable while they make a diagnosis or begin therapy, doctors can employ ECMO. ECMO can maintain blood oxygenation and circulation for anyone awaiting a lung or heart transplant.

ECMO for Children and Babies

While children are recuperating from a life-threatening (though curable) condition, the ECMO machine can perform the functions of their heart and lungs. Your kid will be given sustenance during ECMO, comfort drugs, blood thinners to prevent blood clotting, and other supplies to help the blood flow via the ECMO machine.

Veno-Venous vs Veno-Arterial

A temporary mechanical aid that enables sustained cardiopulmonary support is called veno-venous ECMO (VV-ECMO). It is used in patients with respiratory failure that poses a life-threatening risk and is a development of the cardiopulmonary bypass system.

Even though this highly complicated approach has significant dangers, such as infection, hemorrhage, and thromboembolic events, it can nonetheless give pretty comprehensive breathing support. While traditional VV-ECMO circuits often use the cannulation of two vessels, it is now feasible to provide VV-ECMO assistance with only one cannula.

The most sophisticated temporary life support method, veno-arterial extracorporeal membrane oxygenation (VA-ECMO), is unique because it offers simultaneous gas exchange and instant, full hemodynamic support.

In addition, it is commonly used to treat people with pulmonary hypertension and thromboembolism, especially in sudden decompensation, resulting in the need for an extracorporeal membrane oxygenation device.

Burgeoning Medical Awareness of ECMO Devices

As more patients become aware of the advantages of cardiopulmonary aid for severe cardiac and respiratory disorders, the frequency of ECMO therapy acceptance will grow. The introduction of patient education initiatives on ECMO devices and their uses in developing nations like the Middle East and Asia has increased demand for these devices.

For example, the inaugural Abu Dhabi Trauma and ECMO conference was held in May 2022 and was organized by the Department of Health Abu Dhabi (DoH) to improve the standard of care for patients with trauma, lay out a plan for individuals who need ECMO, emphasize the value of trauma management and ECMO programs in the healthcare industry, and discuss the most recent applications and experiences.

13 luglio 2023

North America is Dominating Rotator Cuff Injury Treatment Industry

In 2022, the rotator cuff injury treatment market was worth around USD 1,098.4 million, and it is projected to advance at a 5.1% CAGR from 2022 to 2030, hitting USD 1,633.5 million in 2030, as per P&S Intelligence.

This growth can be credited to the increasing frequency of shoulder injuries because of sports, technological advancements in arthroscopic surgery equipment, and snowballing osteoarthritis issues in the elderly populace.

In 2022, The surgical treatment category held the biggest revenue share, approximately 55%, and is projected to continue with the dominant till the end of the decade. Credited to the growing occurrence of rotator cuff injuries and the supportive therapeutic reimbursement for the surgery.

In 2022, North America led the industry by generating the largest revenue share, of approximately 45%. This can be credited to the increasing number of product launches, constant research and development, and commercialization of advanced treatments for rotator cuff injuries.

Furthermore, the snowballing subsidy and a number of partnerships between main businesses, a supportive regulatory environment for rotator cuff operations, along with favorable government guidelines for the sale of related goods fuels the industry. Furthermore, the considerable engagement in sports will enable the continent to continue with its dominance throughout the decade.

Hence, the increasing frequency of shoulder injuries because of sports, technological advancements in arthroscopic surgery equipment, and snowballing osteoarthritis issues in the elderly populace are the major factors contributing in the growth of the rotator cuff injury treatment market.

12 luglio 2023

What Are Two Ways Stomas Are Created and How to Care for Them?

A stoma is an opening in your abdomen that permits waste to remove from your body, rather than going via your digestive system. They’re utilized when part of your bladder or bowels either requires to heal or be detached.

To make a stoma, your surgeon will pull part of your large or small intestine onto the surface of your skin and stitch it onto an opening in your abdomen. The intestine ends and drains waste into an ostomy appliance, which is a bag attached to your stoma. Stomas are generally red, round, and moist, and they measure about 1 or 3 inches wide.

Numerous individuals use the terms “ostomy” and “stoma” interchangeably, but they do have a little different meaning:

An ostomy denotes the real opening in your abdomen.

A stoma denotes the end of the intestine that’s stitched into the ostomy.

Ostomies can be temporary and permanent. If you have an organ that is enduringly damaged, you’ll likely require a permanent one. However, if part of your intestine just requires to heal for a while, you may have a temporary ostomy.

The stoma care market is experiencing growth and is projected to reach USD 3,882.1 million by 2030.

What are the different types?

There are numerous kinds of stoma, reliant on the process utilized to create them:

Colostomy- A stoma is made with part of your colon, also called your large intestine, to avoid your rectum. In some cases, you may have the minor part of your colon removed, directing to a permanent stoma. A colostomy can also be impermanent if your colon is just required to heal. You may require a colostomy if you have rectal or colon cancer, a colon wound, or a blockage in your colon.

Urostomy- Your medic will make a bag using your small intestine. They’ll attach your ureters to this bag so that urine can gutter outside of your body without passing via your bladder. You may require a urostomy if your bladder is unhealthy or injured.

What kind of care is involved?

Your ostomy appliance comprises a bag that your stoma pipes into. Liable on the kind of bag you have, you’ll require to change it every four to seven days. When you change the bag, clean the skin around your stoma with mild warm water and let it dry totally. You don’t require to utilize soap, but if you do, make sure it’s very light and odorless, While the bag is detached, look for any signs of blood, irritation, or variations in the size and color of your stoma.

Colostomy surgery is leading the industry, based on surgery-type segmentation. This can be ascribed to the increasing occurrence of colon cancer and the growing number of colostomy methods.

For example, as per the United Ostomy Associations of America, around 100,000 ostomy operations are done in the U.S. annually.

Hence, the rising aging populace, the mounting board population of people suffering from inflammatory bowel illnesses and bladder and colorectal cancers, improved technology, the growing number of stoma and ostomy operations of the intestine, and fascinating reimbursement systems in developed countries are the major factors driving the market.

11 luglio 2023

North America is Dominating Closed System Transfer Devices Industry

The global closed system transfer devices market will touch USD 3,516 million by 2030, advancing at a CAGR of 15.20% during 2022–2030.

This growth can be credited to the growing need for CSTDs to confront the damaging effects of medications including antineoplastic or cytotoxic agents utilized to treat cancer, hormone agents, bioengineered drugs, and hormone agents.

Oncology drugs are the most vital extents of attention for pharmaceutical businesses globally. With new advancements in the field of the drug, there will be more treatment choices existing and more safety problems will come with every new drug.

The hospitals & clinics category, generated the highest revenue share, based on the end users. This is because of the presence of a vast populace base of cancer patients, who are being cured and treated by a huge count of clinics and hospitals. Because of a high count of cancer cases and healthcare amenities, the count of healthcare employees who are at work directly in contact with dangerous medications is quite high.

North America had the largest market share in 2022, because of the snowballing knowledge of healthcare employees regarding harmful drugs and their impacts, and the existence of key players who are making these devices in the continent. In North America, the U.S. generates a higher revenue share, credited to the huge number of cancer cases in the nation.

Hence, the growing need for CSTDs to confront the damaging effects of medications including antineoplastic or cytotoxic agents utilized to treat cancer, hormone agents, bioengineered drugs, and hormone agents, these are the major factors contributing in the growth of the closed system transfer devices market.

10 luglio 2023

Liquid Handling System Industry to Observe Fastest Growth In Asia-Pacific

In 2022, the liquid handling system market was USD 4,692 million, and it is expected to reach a value of USD 6,521 million growing at a rate of 4.20%, by 2030 as told in a report by P&S Intelligence.

This growth is credited to the developing life science industry, increasing investment to develop efficient and innovative therapeutic agents by various companies, and the growing incidence of chronic diseases.

Furthermore, the demand for these products has increased considerably due to the outbreak of the COVID-19. These systems were used in all sorts of laboratory work during the testing of samples for the virus.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=liquid-handling-system-market

India and China, are offering opportunities to various life science companies and drug manufacturers. For example, Pfizer Inc. set up a research and development center at the Indian Institute of Technology Madras, to enhance pharmaceutical research in India.

Significant demand is expected for automated systems in the near future. These variants offer accurate dispensing and decrease the requirement for manpower.

Pipettes held the largest liquid handling system market share, of over 21%, in 2022, and it will remain like this in the years to come. This is because of the production of advanced pipettes and the increasing number of pipette calibration service providers.

In 2022 liquid handling systems held a major share as these systems are frequently used in drug making. Over 20,000 drugs will be launched in the years to come. These systems are crucial at every stage of the drug development process.

Liquid handling systems are used in research activities for toxicity screening, drug screening, forensic testing, biopharma production, tissue engineering, and drug discovery and development. The key driving factor in the industry is the government’s involvement in making a more organized life science industry.

The growing number of mergers and acquisitions is a key trend in the industry. The reason behind this is to increase product portfolios for the company, geographical expansion, achieving a larger customer base, and the profit share.

North America accounted for the largest share in 2022, at approximately 36%. This is credited to the increasing merger & acquisition between biotechnology companies. Furthermore, to develop effective therapies various companies are investing in the consumer healthcare business.

APAC will grow the fastest, at a rate of over 5.1%, in the years to come, owing to the rising investments in biotechnology.

China held the largest share in 2022, and it will advance significantly in the coming years. This is mainly credited to the number of research and development activities taking place in the life sciences industry.

Due to the developing life science industries, growing investment to develop effective and innovative therapeutic agents by companies, and rising incidence of chronic diseases, the demand for liquid handling system will grow considerably in the coming years.

3 luglio 2023

Mineral Supplements Market Has the Largest Share in Asia-Pacific

It is stated by an expert at a market research institution, P&S Intelligence, the total revenue generated by the mineral supplements market will reach USD 21 billion by 2030, powering at a rate of 5.3% in the years to come.

This has a lot to do with the increasing acceptance of these products for reducing the probability of a number of chronic diseases, such as osteoporosis, anemia, and cancer.

Calcium had the largest share of revenue, of over 26%, in the recent past. This is due to the increasing cases of osteoporosis globally, mostly in the elderly population and women.

Furthermore, the introduction of innovative calcium-based tablets by pharma companies is resulting in enhanced demand for them globally.

Potassium will have the fastest growth in the years to come, because of the growing consciousness concerning the benefits of this nutrient, like the formation of a fluid balance in the body, smooth muscle tightening, and continuous transmission of nerve impulses.

Tablets dominated the mineral supplements market, on the basis of their formulation. This is because tablets are a perfect form of dosage, lucrative, easily obtainable, and have an extended shelf life.

The liquid category will grow the fastest in the years to come, the main reason for this is due to the increasing requirement for liquid supplements, easily absorbed and have greater bioavailability.

Adult women dominated the industry, mainly attributable to the strong necessity for potassium, zinc, and calcium among women throughout the prenatal and postnatal phases. Also, for reducing the danger of any abnormality in babies, the intake of these is necessary for mothers.

Likewise, the hectic work schedules and altering lifestyles of working women are creating an imbalance of nutrients, which will increase the consumption of added minerals. Furthermore, the growing prevalence of diabetes, obesity, and CVDs amongst adult women globally is powering the industry.

APAC had the largest share of above 50%, mostly credited to the growing occurrence of chronic diseases and the presence of numerous stalwarts. Also, the advent of contract manufacturing firms in the Philippines, India, and China, will offer substantial predictions for the advancement of the region.

Furthermore, the speedily increasing disposable income and strengthening emphasis on adopting a healthy lifestyle are leading to a surge in the industry.

In addition, the mounting count of fitness centers, health clubs, and gyms, accompanied by the surging consciousness about fitness amongst youngsters will power the demand for these products.

It is because of the growing implementation of preventive healthcare practices all over the world, the demand for mineral supplements will grow even more in the years to come.

28 giugno 2023

Disposable Plastic Blood Bag Industry Insights, Leading Players and Forecast Report 2030

The disposable plastic blood bags market will power at a rate of 6.1% in the years to come, to touch USD 530.0 million by 2030. Not just blood, they support in the in the separation of white blood cells, plasma, red blood cells, platelets, and cryoprecipitate, for treatment of numerous disorders, which is the main reason of their increasing sales all over the world.

Single disposable plastic blood bag was the most used alternative in the past. This has a lot to do with the increase in the number of transfusion procedures, increase in the cases of trauma and accidents, and increase in the incidence of numerous hematologic illnesses.

Hospitals mad the most use of these bags, with a share of over 60% in the past. These come good for collection of blood and transfusion in hospitals as a result of their numerous useful qualities and biocompatibility characteristics.

The requirement for blood supply in hospitals has augmented as a result of the increasing prevalence of chronic ailments, for example cancer, and the increasing volume of surgical procedures.

These factors have a lot to do with healthcare industry expansion and the increase in the hospital and health clinic count. The bags provide a safe environment for the transportation and storage of blood and its components.

Disposable plastic blood bags are majorly sold with the help of tender-based channel. Producers’ strategies must comprise sales with the help of tenders in the healthcare industry.

With the support of a competitive bidding procedure, a tender comes good in the bulk obtaining of services and products.

Tender-based procurements are often used for the purpose of reducing the cost through the entire journey of the contract. As a result of the price competition, the acceptance of this technique for lowering the cost would go up significantly.

Apart from decreasing the inadequacies brought on by segmented distribution systems, it often produces economies of scale.

North American disposable plastic blood bags market will continue to be the regional leader in the years to come. The increasing use of hematological and pathological tests, along with the high prevalence of chronic ailments, offers lucrative growth prospects.

Also, the existence of a well-resourced healthcare infra, snowballing donation activities, and attempts of the government for promoting the usage of these bags for preventing HAI, which are a key risk with glass bottles of blood, impact the growth in a positive manner.

There is a sharp rise in the elderly population all over the world, and because of this, the demand for disposable plastic blood bags will be impacted in a positive manner.

26 giugno 2023

Ventilator Industry Insights, Top Players and Demand Forecast Report 2030

The ventilator market will grow at a rate of 7.1% in the years to come, to touch USD 2,887.32 million by 2030. This growth has a lot to do with the increasing cases of chronic diseases, such as COPD and asthma globally.

Critical care dominated the industry. This is because of the COVID-19 virus, which has affected a lot of global population. This results in the enormous necessity for critical care, because of a lot of hospitalizations.

Smoking is one of the key reasons of COPD. There are a lot of tobacco users in the low or middle-income nations. As per the CDC, cigarette smoking is a major cause of ailment, debility, and death in the U.S., and it causes for over 480,000 fatalities every year.

Therefore, the necessity for critical care increases, which drives the demand for ventilators in this category.

Standard ventilators had the largest share, of above 65%, in the recent past. The development in healthcare facilities and hospitals, and the efficiency of ventilators in variety of applications in numerous care delivery settings will have a favorable effect on the growth of the market in this category.

Adults dominate the ventilator market, as per a report by P&S Intelligence. This is because they are more susceptible to ailments such as asthma, COPD, and respiratory diseases. Furthermore, the increasing count of smokers and the growing elderly population are powering the category growth.

Invasive ventilators had the largest share in the industry with about 60%. This has a lot to do with the increasing number of ICU beds, which has ventilators, snowballing occurrence of respiratory illness, and a growing count of surgical procedures happening, all over the world.

There is also an increase in the number of hospital admissions, mainly because of the outbreak of the pandemic. These types of ventilators are a major component of intensive care units and emergency for treating ill patients.

North America dominated the market with over 30% share, in 2021. This is because of the increasing prevalence of respiratory ailments like bronchitis and asthma.

COPD is perhaps the biggest threat for the people of this region. Likewise, as a result of the advanced healthcare infra in Canada and the U.S., improved ventilator systems are used more often in the region. For example, as per data made available, there were 77,000 ventilators in the hospitals of the country hospitals as of March 2020 and over 8,000 ventilators in the nursing homes of America.

It is due to the increasing count of hospital beds, the demand for ventilators will increase even further by the end of this decade.

20 giugno 2023

Battling and Defeating Cancer With Immunotherapy Drugs

It is quite common to find people suffering from cancer. Cancer was once considered untreatable, but it is not the case with all the developments going on in medical science.

Cancer has everything to do with putting bad impact of the body, that’s why the body is not able to recognize the cancer cells and fight with them. In this blog, there will be information about immunotherapy, which is a particularly recent treatment for cancer.

Immunotherapy utilizes the immune system of a person for battling cancer. It usually has fewer side effects than a chemotherapy treatment.

Immunotherapy is done on the basis of immune cells that have the potential of recognizing and killing cancer cells can be produced in the labs and given to patients for the treatment of cancer. Several immunotherapy drugs have got the approval by the FDA or are in the process of clinical trials for determining their efficiency in treating various cancers.

Preparing Immune System To Fight Cancer

Immunotherapies makes use of different methods for battling with cancer cells. There are generally three types of Immunotherapies:

Checkpoint inhibitors- It is that process, which disturbs the system of cancer cell signals dodging the immune system into thinking they’re healthy, exposing them, and get them attacked by the immune system

Cytokines- cytokines helping in regulating and directing the immune system are formulated in a lab and injected into the body in larger dose than that, which are produced naturally in the human body.

Cancer vaccines- These are vaccines which reduce the risk of cancer by launching an open attack on the cancer causing viruses, or might help in the treatment of cancers by motivating the immune system for attacking cancer cells in a precise body part.

Immunotherapy might be put to use alone or in combination with other cancer treatments, for example surgery, chemotherapy, radiation and targeted therapy.

Immunotherapy Vs Chemotherapy

Both immunotherapy and chemotherapy are usually employed treatments of cancer using drugs put a halt or slow the rate of growth of cancerous cells. Though, while chemotherapy drugs attack quickly producing cells all over the body, immunotherapy activates the immune system’s capability to recognize and attack the cells causing cancer.

What are the Benefits of Immunotherapy

Immunotherapies are less common than chemotherapy as a cancer treatment. But these therapies are a treatment option for various cancers.

Immunotherapies can be more comprehensive and less noxious than other treatments used for treating cancer, as they harness the body power to attack the cancer cells rather than inserting chemicals into the body.

Immunotherapies are an active area of research in cancer therapy, and many of the new treatments are waiting to be approved for use for the treatment of cancer.

Due to the increasing prevalence of Chronic diseases around the world, the demand for immunotherapy drugs will further increase in the years to come, and will reach a value of USD 210,752 million by the end of this decade.

19 giugno 2023

North America Is Dominating Surgical Sutures Industry

The total value of the global surgical sutures market was USD 4.1 billion in 2021, and it will rise at a growth rate of above 5.9% shortly, reaching USD 6.8 billion by 2030, according to P&S Intelligence. This development can be credited to the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe.

In recent years, absorbable sutures led the industry, with a market share of above 52%, and the same is also estimated to be in the leading position throughout the forecast period. This is mainly because of its timings, as it takes less time and reduces the count of patient visits to hospitals.

Internal operations regularly use absorbable sutures because they naturally and securely break in the body. Hydrolytic, proteolytic, and enzymatic devices are utilized to degrade these sutures. Reliant on the material used for the process, the breakdown procedure characteristically takes 9 days to 8 weeks. Different materials, polyglycolic acid, including catgut, polylactic acid, and polydioxanone, are utilized to make absorbable sutures.

In 2021, the cardiovascular surgery category had the largest surgical sutures market share, approximately 30.0%, because of the rising occurrence of cardiovascular illnesses. Cardiovascular operations, such as heart transplantation operations, are undertaken to cure difficulties of valvar heart illnesses, ischemic heart illnesses, and congenital heart illnesses.

Surgical procedures involving cardiovascular systems are the most complex and high-risk, necessitating sutures of the highest quality and suitability. An increase in the number of patients with heart disorders leads to a rise in the usage of cardiovascular surgeries, boosting the demand for sutures in the market.

In recent years, the North American region dominated the industry by generating the highest revenue share, of over 40%. This can be credited to the growing elderly populace, the growing count of road accidents, the rising cases of obesity and diabetes, and the growing burn cases in the continent.

Furthermore, the augmented requirement for improved surgical techniques and products, including biocompatible surgical sutures with antimicrobial coatings, is boosting the development of the industry in North America.

Hence, the growing count of medical procedures and the growing occurrence of chronic illnesses throughout the globe are the major factors propelling the surgical sutures market.